Clock-Modulating Activities of the Anti-Arrhythmic Drug Moricizine

Abstract

Dysregulated circadian functions contribute to various diseases, including cardiovascular disease. Much progress has been made on chronotherapeutic applications of drugs against cardiovascular disease (CVD); however, the direct effects of various medications on the circadian system are not well characterized. We previously conducted high-throughput chemical screening for clock modulators and identified an off-patent anti-arrhythmic drug, moricizine, as a clock-period lengthening compound. In Per2:LucSV reporter fibroblast cells, we showed that under both dexamethasone and forskolin synchronization, moricizine was able to increase the circadian period length, with greater effects seen with the former. Titration studies revealed a dose-dependent effect of moricizine to lengthen the period. In contrast, flecainide, another Class I anti-arrhythmic, showed no effects on circadian reporter rhythms. Real-time qPCR analysis in fibroblast cells treated with moricizine revealed significant circadian time- and/or treatment-dependent expression changes in core clock genes, consistent with the above period-lengthening effects. Several clock-controlled cardiac channel genes also displayed altered expression patterns. Using tissue explant culture, we showed that moricizine was able to significantly prolong the period length of circadian reporter rhythms in atrial ex vivo cultures. Using wild-type C57BL/6J mice, moricizine treatment was found to promote sleep, alter circadian gene expression in the heart, and show a slight trend of increasing free-running periods. Together, these observations demonstrate novel clock-modulating activities of moricizine, particularly the period-lengthening effects on cellular oscillators, which may have clinical relevance against heart diseases.

The Polymethoxyflavone Sudachitin Modulates the Circadian Clock and Improves Liver Physiology

“…Noninvasive Piezoelectric Transducer Sleep/Wake Recording: Sleep/wake recording was carried out by using a noninvasive piezoelectric transducer sleep/wake recording system (Signal Solutions, Lexington, KY, USA) as previously described. [57] Briefly, mice were singlehoused in the Piezo system with free access to food and water under the normal LD cycles. The initial 48 h acclimation period was followed by data recording for 2 days.…”

The clock modulator Nobiletin mitigates astrogliosis‐associated neuroinflammation and disease hallmarks in an Alzheimer’s disease model

“…Circadian and sleep assays were conducted as previously described. 56,57 Briefly, 16-month old male mice (n = 7-10) were single housed in wheel-running cages in a 12:12 h LD controlled cabinet (300 lux, room temperature at 22.6-24.1°C and relative humidity 38%-42%). After 3 weeks of acclimation, animals were subjected to constant darkness (DD).…”

“…For sleep analysis, 10-month old male mice (n = 7-10) were tested in a noninvasive piezoelectric transducer sleep/wake recording system (Signal Solutions) as previously described. 39,57 Before testing, mice were acclimated for 2 days in individually housed cages with free access to food and water under 12:12 h LD cycle. The initial 48 h acclimation period was followed by actual data recording for 5 days.…”

Regulation of headache response and transcriptomic network by the trigeminal ganglion clock

“…RNA extraction and RT-PCR analysis were performed as previously described. 35 For RT-PCR analysis of the Cgrp gene in TG tissue, 10 mg/ kg NTG was administered intraperitoneally every other day for 9 days, TGs were removed from mice and total RNA were extracted by using PureXtract RNAsol Reagent (GenDEPOT). The primer sets for Cgrp used F: 5′-atcaagagtcaccgcttcgc-3′, R: 5′-cctgggctgctttccaagat-3′.…”